Series C Funded Health Care Startups
Across these 50 Series C health care rounds, the largest disclosed amount is Truveta’s $320M (2025-01-13).
Across these 50 Series C health care rounds, the largest disclosed amount is Truveta’s $320M (2025-01-13). The next-largest disclosed rounds sit much lower (e.g., VeraDermics $150M on 2025-10-13; Capstan Medical $110M on 2024-12-11; Talkiatry $130M on 2024-06-18), so Truveta’s deal size dwarfs the rest of the disclosed figures in this view.
The timing also clusters heavily: 12 of the 50 rounds fall between 2024-10-01 and 2025-10-13, and California appears frequently (e.g., VeraDermics, Wellth is LA-based, Zenflow in South San Francisco, Nusano in Valencia, Talkiatry is New York but multiple California entries recur, including Capstan Medical in Santa Cruz). Geographic spread is international with multiple France/UK/Germany/Canada rounds (e.g., Tricares in Paris on 2022-09-16 and Diabeloop in Grenoble on 2022-06-02), while disclosure is mixed: 2 entries are “undisclosed” (Leo Cancer Care on 2024-06-11; SafeRide Health on 2023-10-06) and another 1 is “undisclosed” (Beep Saúde on 2022-11-14), for 3 undisclosed amounts total. Rounds span 2022-05-04 (Apnimed) through 2025-10-13 (VeraDermics).
Most recent rounds
50 shownRelated listings
Frequently asked
What does the largest disclosed Series C round look like versus the rest of the list?
Truveta’s $320M (2025-01-13) is the largest disclosed amount in these 50 rows, and it sits far above the next-largest disclosed figures such as VeraDermics’ $150M (2025-10-13) and Capstan Medical’s $110M (2024-12-11).
Do rounds cluster in a recent date window, or are they evenly spread across the multi-year range?
They cluster toward the most recent year: 12 of the 50 rounds occur between 2024-10-01 and 2025-10-13, including Capstan Medical ($110M, 2024-12-11) and Truveta ($320M, 2025-01-13). The oldest dated entry is Apnimed on 2022-05-04, showing a long tail back to 2022.
Is there a city or country pattern, or is this globally distributed without a hub?
The list is multinational, with repeated European locations (e.g., Tricares in Paris, 2022-09-16, and Diabeloop in Grenoble, 2022-06-02). At the same time, the US—especially California—shows multiple entries (e.g., VeraDermics in New Haven is US, but California includes Capstan Medical in Santa Cruz (2024-12-11), Zenflow in South San Francisco (2024-11-18), and Nusano in Valencia (2024-10-01)).
Are there disclosure outliers that affect how to interpret “largest round” comparisons?
Three entries show “undisclosed” amounts (Leo Cancer Care on 2024-06-11; SafeRide Health on 2023-10-06; Beep Saúde on 2022-11-14). These rows can’t be used for disclosed-amount comparisons, but the disclosed outlier remains Truveta’s $320M (2025-01-13) among the rest of the disclosed figures.
Which recent entries are most likely to matter for fast pipeline outreach based on timing?
Within the newest window, several rounds land in late 2024 to 2025, including VeraDermics ($150M, 2025-10-13), Wellth ($36M, 2025-08-20), and Truveta ($320M, 2025-01-13). Earlier 2023 rounds also appear, such as Star Therapeutics ($90M, 2023-09-05), but the densest concentration is in 2024-10 through 2025-10.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.